Security key
87165D208
Synergy CHC Corp. - Common Stock, par value $0.00001 per share (SNYR)
CUSIP: 87165D208
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, par value $0.00001 per share
- Total 13F shares
- 1,297,093
- Total 13F value
- $2,412,592
- Share change
- -343,005
- SEC-reported price per share
- $1.86
- Number of holders
- 12
- Value change
- -$874,135
- Number of buys
- 9
- Number of sells
- 4
- Shares outstanding
- 9,605,095
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
12
Top holders
10
SNYR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Synergy CHC Corp. SEC filings
Synergy CHC Corp. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87165D208
Recent filing periods:
Ownership snapshot
Top reported holders of SNYR - Synergy CHC Corp. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Knight Therapeutics Inc.
Disclosed value leader
Knight Therapeutics Inc.
Comparable rows
12/13
Latest evidence
30 Sep 2025
3/4/5
13D/G
13F
Lead comparable stake: 20%
1 rows are not safely comparable across share classes.
13D/G row: Knight Therapeutics Inc.
Showing 1-6 of 13 holder rows.
Quick read
Knight Therapeutics Inc. leads the comparable SEC ownership view at 20%.
12 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Knight Therapeutics Inc.'s linked filing trail.
Comparable ownership
Top 5
Knight Therapeutics Inc.
20%
GRATIA CAPITAL, LLC
5.8%
HEARTLAND ADVISORS INC
5.7%
SANDERS MORRIS HARRIS LLC
4.1%
VANGUARD GROUP INC
0.69%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 13 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Knight Therapeutics Inc. |
3/4/5
13D/G
10%+ Owner
|
20%
from 13D/G
|
$6,020,347
1,911,414 shares
mixed-class rows
|
— | 11 Jun 2025 |
| GRATIA CAPITAL, LLC |
13F
Company
|
5.8%
|
$1,354,200
555,000 shares
|
— | 30 Sep 2025 |
| HEARTLAND ADVISORS INC |
13F
Company
|
5.7%
|
$1,342,000
550,000 shares
|
— | 30 Sep 2025 |
| SANDERS MORRIS HARRIS LLC |
13F
Company
|
4.1%
|
$955,753
391,702 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
0.69%
|
$161,058
66,007 shares
|
— | 30 Sep 2025 |
| Warberg Asset Management LLC |
13F
Company
|
0.35%
|
$81,786
33,519 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
12
Shares
1,297,093
Rows available
12
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
11
Q4 2025 holders
12
Holder diff
1
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend